MYELOKATHEXIS

Clinical trials for MYELOKATHEXIS explained in plain language.

Never miss a new study

Get alerted when new MYELOKATHEXIS trials appear

Sign up with your email to follow new studies for MYELOKATHEXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Rare disease drug shows promise in reducing infections

Disease control Completed

This study tested two drugs, plerixafor and G-CSF, in 20 people with WHIM syndrome, a rare genetic condition that causes frequent infections and warts. Participants received each drug for a year and tracked their infections. The goal was to see which drug better reduced infection…

Matched conditions: MYELOKATHEXIS

Phase: PHASE2, PHASE3 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control

Last updated Jun 28, 2026 00:00 UTC

MYELOKATHEXIS

Get alerted when new MYELOKATHEXIS trials appear

Rare disease drug shows promise in reducing infections